Cholesterol screening guidelines: Consensus, evidence, and common sense

Circulation

Volumn 95, Issue 6, 1997, Pages 1642-1645

  Garber, Alan M ^a,c   Browner, Warren S ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

cholesterol; hypercholesterolemia; tests

Indexed keywords

CHOLESTEROL BLOOD LEVEL; DIET; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; ONSET AGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING;

EID: 0030944941     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.6.1642     Document Type: Review

References (28)

1. Task Force on Risk Reduction. Cholesterol screening in asymptomatic adults: no cause to change. Circulation. 1996;93:1067-1068.
2. Garber AM, Browner WS. American College of Physicians guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 1996;124:515-517.
3. Garber AM, Browner W, Hulley S. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 1996;124:518-531.
4. Garber AM, Sox HC, Littenberg B. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989;110:622-639.
5. Eddy DM. Common Screening Tests. Philadelphia, Pa: American College of Physicians; 1991.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
7. Smith R. Editor's choice: celebrating evidence-based everything. BMJ. 1995;310:1081i.
8. Canadian Consensus Conference on Cholesterol. Final report. Can Med Assoc J. 1988;139:1-8.
9. United States Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd Ed. Baltimore, Md: Williams & Wilkins; 1996.
10. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1993 update; 2: lowering the blood total cholesterol level to prevent coronary heart disease. Can Med Assoc J. 1993;148:521-538.
11. Toronto Working Group on Cholesterol Policy. Asymptomatic hypercholesterolemia: a clinical policy review. J Clin Epidemiol. 1990;43:1028-1121.
12. Conseil d'Evaluation des Technologies de la Sante du Quebec (CETS). Cholesterol and Coronary Disease: Intervention Strategies in the Light of Present Knowledge. Montreal, Canada: CETS; 1993.
13. Health Services Utilization and Review Commission. Cholesterol Testing and Treatment in Adults. Saskatoon, Canada: Saskatchewan Health Services Utilization and Research Commission; 1995 (HSURC final report).
14. National Cholesterol Education Program. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: the Expert Panel Arch Intern Med. 1988;148:36-69.
15. Wysowski DK, Kennedy DL, Gross TP. Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA. 1990;263:2185-2188.
16. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: a new look at old data. Circulation. 1995;91:2274-2282.
17. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
18. Scandinavian Simvastatin Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study. Lancet. 1995;345:1274-1275.
19. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991;303:953-957.
20. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-373.
21. Robertson I, Phillips A, Mant D, Thorogood M, Fowler G, Fuller A, Yudkin P, Woods M. Motivational effects of cholesterol measurement in general practice health checks. Br J Gen Pract. 1992; 42:469-472.
22. Elton PJ, Ryman A, Hammer M, Page F. Randomised controlled trial in northern England of the effect of a person knowing their own cholesterol concentration. J Epidemiol Community Health. 1994;48: 22-25.
23. Barratt A, Reznik R, Irwig L, Cuff A, Simpson JM, Oldenburg B, Horvath J, Sullivan D. Work-site cholesterol screening and dietary intervention: the Staff Health Heart Project. Am J Public Health. 1994;84:779-782.
24. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ. 1994;308:313-320.
25. Hanlon P, McEwcn J, Carey L, Gilmour H, Tannahill C, Tannahill A, Kelly M. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ. 1995;311:1609-1611.
26. 1996 Drug Topics Red Book. Montvale, NJ: Medical Economics Company; 1996.
27. Pederson TR, Kjekshus J, Berg K, Olsson AG, Wilhelmsen L, Wedel H, Pyorala K, Miettinen T, Haghfelt T, Faergeman O, Thorgeirsson G, Jonsson B, Schwartz JS. Cholesterol lowering and the use of healthcare resources: results of the Scandinavian Simvastatin Survival Study. Circulation. 1996;93:1796-1802.
28. Goldman L, Weinstein M, Goldman P, Williams L. Cost-effectiveness of HMG Co-A reductasc inhibition for primary and secondary prevention of CHD. JAMA. 1991;265:1145-1151.